First Gene Therapy for Deadly Form of Muscular Dystrophy Gets FDA Approval for Young Kids

The FDA OK'd the treatment only for children ages 4 and 5, based on study results showing the therapy helped produce a protein needed for muscle growth, which is missing in boys with the condition.
Source: Arkansas Business - Health Care - Category: American Health Source Type: news